Purpose
High proliferation rate is a hallmark of cancer. The mitotic index is a useful and simple method for analysis of cell proliferation. However, the practical utility of mitotic index as a predictor of prognosis in patients with hepatocellular carcinoma (HCC) has not been determined. Therefore, we examined mitotic index as a prognostic marker in HCC patients.
Materials and Methods
We counted the number of mitotic cells in 10 high-power fields of the tumor area on hematoxylin and eosin–stained slides representing 282 surgically resected HCCs. The highest number of mitotic cells was defined as the mitotic index.
Results
High mitotic index was observed in 127 of 282 HCCs. High mitotic index showed significant association with younger age, larger tumor size, higher Edmondson grade, microvascular invasion, major portal vein invasion, intrahepatic metastasis, higher American Joint Committee on Cancer (AJCC) T-stage, higher Barcelona Clinic Liver Cancer (BCLC) stage, higher alpha-fetoprotein level, hepatitis B virus etiology, and liver cirrhosis. Patients with high mitotic index had shorter disease-specific survival (DSS) (p < 0.001) and tended to have shorter recurrence-free survival (p=0.112). In subgroup analysis among patients with a larger tumor size, microvascular invasion, intrahepatic metastasis, higher AJCC T-stage, and higher BLCL stage, high mitotic index showed unfavorable influences on DSS (p=0.001, p=0.008, p=0.003, p=0.012, and p < 0.001, respectively). In addition, high mitotic index was an independent predictor of shorter DSS (p=0.004).
Conclusion
High mitotic index may be a novel predictor of DSS in patients with HCC and may have utility as an auxiliary prognostic factor in HCC.
Citations
Citations to this article as recorded by
Hepatocellular carcinoma arising from ectopic liver tissue: a systematic review of the literature Sami Akbulut, Tevfik Tolga Sahin European Journal of Gastroenterology & Hepatology.2026; 38(3): 243. CrossRef
Genotoxicity assessment of cardioprotective terbium hydroxide nanorods: A comprehensive in vitro and in vivo study Vishnu Sravan Bollu, Susheel Kumar Nethi, Sanchita Tripathy, Sunil Misra, Chitta Ranjan Patra Journal of Drug Delivery Science and Technology.2026; 121: 108273. CrossRef
Association of TERT promoter mutations with early recurrence in hepatocellular carcinoma: a subgroup analysis in a Vietnamese cohort Hanh Thi Tuyet Ngo, Duy Duc Nguyen, Hoang Anh Vu, Thao Thi Phuong Doan, Minh-Xuan Dang, Phat Thi Hong Ho, Khoa Anh Luong BMC Cancer.2026;[Epub] CrossRef
Optimization of Mitotic Index Quantification Using the Amnis ImageStream Imaging Flow Cytometer I. V. Kholodenko, K. N. Yarygin, Y. S. Kim Bulletin of Experimental Biology and Medicine.2025; 179(4): 556. CrossRef
Multi-gradient permutation survival analysis identifies mitosis and immune signatures steadily associated with cancer patient prognosis Xinlei Cai, Yi Ye, Xiaoping Liu, Zhaoyuan Fang, Luonan Chen, Fei Li, Hongbin Ji eLife.2025;[Epub] CrossRef
Prognostic Role of Mitotic Index in Hepatocellular Carcinoma: Potential Clinical Implications for Very Early Stage Disease Sangjoon Choi, Yoon Ah Cho, Sujin Park, Hyun Hee Koh, Boram Park, Kyunga Kim, Ju Dong Yang, Sang Yun Ha Journal of Hepatocellular Carcinoma.2025; Volume 12: 3077. CrossRef
BCG as an Innovative Option for HCC Treatment: Repurposing and Mechanistic Insights Farzam Vaziri, Tahereh Setayesh, Ying Hu, Resmi Ravindran, Dongguang Wei, Yu‐Jui Yvonne Wan Advanced Science.2024;[Epub] CrossRef
Photo-triggered caffeic acid delivery via psyllium polysaccharide- gellan gum-based injectable bionanogel for epidermoid carcinoma treatment Sirajunnisa Abdul Razack, Yeachan Lee, Sivakumar Bose, Hwarang Shin, Won-Kyo Jung, Hyun Wook Kang International Journal of Biological Macromolecules.2024; 267: 131166. CrossRef
Prognostic Factors after Hepatectomy for Hepatocellular Carcinoma—The Importance of Pathological Immunophenotyping, the Steatohepatitic Subtype and the Impact of the Hepatic Pedicle Clamping Lorrane Viana, Rui Caetano Oliveira, Ricardo Martins, Henrique Alexandrino, Maria Augusta Cipriano, José Guilherme Tralhão Gastrointestinal Disorders.2024; 6(2): 402. CrossRef
The prognostic role of mitosis index, stage and grade of endometrial cancer in Dr. Soetomo General Academic Hospital Surabaya, Indonesia, in 2018-2020 Farida Umi Choviva, Willy Sandhika, Pungky Mulawardhana Majalah Obstetri & Ginekologi.2024; 32(2): 74. CrossRef
miR-22 gene therapy treats HCC by promoting anti-tumor immunity and enhancing metabolism Ying Hu, Tahereh Setayesh, Farzam Vaziri, Xuesong Wu, Samuel T. Hwang, Xin Chen, Yu-Jui Yvonne Wan Molecular Therapy.2023; 31(6): 1829. CrossRef
Pan-cancer evaluation of clinical value of mitotic network activity index (MNAI) and its predictive value for immunotherapy Xuanyu Mao, Yimeng Cai, Sarah Long, Jesus Perez-Losada, Jian-Hua Mao, Hang Chang Frontiers in Oncology.2023;[Epub] CrossRef
Differential expression of “A Disintegrin and Metalloproteinase 10” in hepatocellular carcinoma and the noncancerous hepatic tissues: Contribution to HCV-promoted hepatocarcinogenesis AmalAbd El Hafez, BasemH Elesawy, HebaS E. I. Hany Indian Journal of Pathology and Microbiology.2023; 66(3): 517. CrossRef
Hepatocellular Carcinoma's Characteristics in an Endemic Country: A Closer Examination of Tumor Grade and Microvascular Invasion Ignasia Andhini Retnowulan, Marini Stephanie, Nur Rahadiani, Ridho Ardhi Syaiful, Ening Krisnuhoni Siriraj Medical Journal.2023; 75(11): 817. CrossRef
Dependence of the Ki67 Labelling Index of Selected Canine Tumours on Patient Age, Sex and Tumour Size Theresa C. Firsching, Kristina Dietert, Alexander Bartel, Marcus G. Doherr, Achim D. Gruber Journal of Comparative Pathology.2022; 193: 1. CrossRef
CXCR2 inhibition enables NASH-HCC immunotherapy Jack Leslie, John B G Mackey, Thomas Jamieson, Erik Ramon-Gil, Thomas M Drake, Frédéric Fercoq, William Clark, Kathryn Gilroy, Ann Hedley, Colin Nixon, Saimir Luli, Maja Laszczewska, Roser Pinyol, Roger Esteban-Fabró, Catherine E Willoughby, Philipp K Hab Gut.2022; 71(10): 2093. CrossRef
Utility of Serum Ki-67 as a Marker for Malignancy in Dogs Annkathrin Estaller, Martin Kessler, Axel Wehrend, Johannes Hirschberger, Stephan Neumann Animals.2022; 12(10): 1263. CrossRef
Validation of ZMYND8 as a new treatment target in hepatocellular carcinoma Sangjoon Choi, Keun-Woo Lee, Hyun Hee Koh, Sujin Park, So-Young Yeo, Jae-Won Joh, Moon Seok Choi, Seok-Hyung Kim, Cheol-Keun Park, Sang Yun Ha Journal of Cancer Research and Clinical Oncology.2021; 147(12): 3517. CrossRef
Bioinformatics Analysis Identifies Precision Treatment with Paclitaxel for Hepatocellular Carcinoma Patients Harboring Mutant TP53 or Wild-Type CTNNB1 Gene Jiunn-Chang Lin, Tsang-Pai Liu, Vivin Andriani, Muhammad Athoillah, Chih-Yang Wang, Pei-Ming Yang Journal of Personalized Medicine.2021; 11(11): 1199. CrossRef
Inositol 1,4,5‑trisphosphate receptor type 3 is involved in resistance to apoptosis and maintenance of human hepatocellular carcinoma Marcone Dos Santos, Andressa França, Antônio Lima Filho, Rodrigo Florentino, Paulo Diniz, Fernanda Lemos, Carlos Gonçalves, Vitor Coelho, Cristiano Lima, Giselle Foureaux, Michael Nathanson, Paula Vidigal, M. Leite Oncology Letters.2021;[Epub] CrossRef
Nimbolide inhibits tumor growth by restoring hepatic tight junction protein expression and reduced inflammation in an experimental hepatocarcinogenesis Amit Kumar Ram, Balasubramaniyan Vairappan, BH Srinivas World Journal of Gastroenterology.2020; 26(45): 7131. CrossRef
Evaluation of the role of Notch1 expression in hepatic carcinogenesis with clinico-pathological correlation Heba Hany, Asem Shalaby, Wagdi Al Kashef, Wageha Kandil, Rehab-Allah Shahin, Hatem El-Alfy, Tarek Besheer, Raghda Farag, Mie Mohamed Pathology.2018; 50(7): 730. CrossRef
Asialoglycoprotein receptor targeted delivery of doxorubicin nanoparticles for hepatocellular carcinoma Sandhya Pranatharthiharan, Mitesh D. Patel, Vinod C. Malshe, Vaishali Pujari, Ajit Gorakshakar, Manisha Madkaikar, Kanjaksha Ghosh, Padma V. Devarajan Drug Delivery.2017; 24(1): 20. CrossRef